Mixing Kenalog and Toradol for Intra-Articular Joint Injection
There is no evidence-based support for mixing triamcinolone acetonide (Kenalog) with ketorolac (Toradol) in the same syringe for intra-articular injection, and this practice is not recommended in current guidelines or FDA labeling.
Current Evidence and Guidelines
Guideline Recommendations for Intra-Articular Injections
Intra-articular corticosteroids are well-established as effective monotherapy for joint conditions:
The AAOS 2022 guidelines support intra-articular corticosteroid injections for knee osteoarthritis, with 19 high-quality and 6 moderate-quality studies demonstrating efficacy, though benefits typically last only 3 months 1.
The American College of Rheumatology conditionally recommends intra-articular corticosteroid injections as initial pharmacologic management for knee osteoarthritis 2.
EULAR 2021 recommendations emphasize that aseptic technique should always be used when performing intra-articular therapies, and the shared decision to inject should consider individualized factors 3.
For acute gout, EULAR guidelines recommend intra-articular aspiration and injection of long-acting steroid as effective and safe treatment, with triamcinolone acetonide 10 mg providing pain relief within 48 hours 4.
FDA-Approved Indications and Administration
The FDA labeling for Kenalog specifies clear administration protocols that do not include mixing with NSAIDs:
For intra-articular administration, initial doses range from 2.5-5 mg for smaller joints and 5-15 mg for larger joints, with doses up to 40 mg for larger areas 5.
The label emphasizes strict aseptic technique and states the suspension should be injected without delay after withdrawal to prevent settling 5.
Kenalog is indicated for intra-articular use in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis, and osteoarthritis 5.
No FDA labeling or guideline recommends combining corticosteroids with ketorolac in a single injection.
Comparative Research: Ketorolac vs. Triamcinolone
Evidence Against Mixing
Recent comparative studies have examined these agents separately, not in combination:
A 2021 randomized controlled trial comparing intra-articular ketorolac versus triamcinolone for hip and knee osteoarthritis found both agents effective when used alone, with ketorolac providing comparable improvement to triamcinolone 6.
A 2020 retrospective study of knee osteoarthritis showed no significant differences in pain relief between ketorolac and corticosteroid injections when used separately, with both producing significant improvements 7.
A 2015 study of hip osteoarthritis demonstrated that intra-articular ketorolac injection was as effective as corticosteroid injection when administered separately 8.
Periarticular vs. Intra-Articular Context
The only evidence for combining these agents comes from periarticular (not intra-articular) injection during total knee arthroplasty:
A 2022 randomized trial examined periarticular multimodal analgesic injection containing either 60 mg ketorolac or 80 mg triamcinolone acetonide as cocktail additives during TKA surgery 9.
This periarticular technique involves injecting into tissues surrounding the joint during surgery, which is fundamentally different from intra-articular injection into the joint space 9.
This periarticular surgical context cannot be extrapolated to office-based intra-articular injections.
Evidence Favoring Triamcinolone Alone
When direct comparisons are made, triamcinolone demonstrates superior outcomes:
For de Quervain's tenosynovitis, triamcinolone injections resulted in significantly lower pain scores (0.7 vs 5.3, P<0.001) and higher functional scores compared to ketorolac at 6 weeks 10.
Triamcinolone hexacetonide is strongly recommended over triamcinolone acetonide for intra-articular injections in juvenile idiopathic arthritis, with moderate-quality evidence supporting more complete and longer duration of response 11.
Clinical Reasoning Against Mixing
Pharmaceutical Considerations
There are multiple reasons to avoid mixing these medications:
Different mechanisms of action: Corticosteroids work through genomic and non-genomic anti-inflammatory pathways, while ketorolac inhibits cyclooxygenase enzymes 1.
Stability concerns: Kenalog is a suspension that requires shaking before use and should be injected without delay after withdrawal to prevent settling in the syringe 5. Mixing with another agent could alter suspension characteristics.
No compatibility data: There is no published evidence on the pharmaceutical compatibility, stability, or safety of mixing these two agents in the same syringe.
Safety Considerations
Combining agents increases potential risks without proven benefit:
Both agents can cause local tissue reactions when injected 5, 10.
The risk of adverse events may be additive or synergistic when combined, though this has not been studied 3.
EULAR 2021 recommendations emphasize that patients must be fully informed of the nature of the injectable and potential risks, which is difficult when using an unstudied combination 3.
Recommended Approach
Use triamcinolone acetonide alone for intra-articular injection:
Administer 5-15 mg for larger joints (knee, shoulder) or 2.5-5 mg for smaller joints according to FDA labeling 5.
Follow strict aseptic technique as mandated by EULAR guidelines 3.
Consider adding local anesthetic (lidocaine) if desired for patient comfort, as this is standard practice mentioned in multiple studies 7, 8.
If inadequate response to corticosteroid injection:
Consider oral NSAIDs as adjunctive therapy rather than mixing injectables 1, 2, 1.
Re-injection decisions should consider benefits from previous injections and other individualized factors 3.
For knee osteoarthritis, if corticosteroid injection fails, escalate to other evidence-based options such as physical therapy or consideration for arthroplasty in appropriate candidates 1.
Common Pitfalls to Avoid
Do not mix medications without evidence: The absence of data on mixing Kenalog and Toradol means unknown risks and no proven additional benefit.
Do not confuse periarticular with intra-articular: Surgical periarticular injection techniques during arthroplasty are not applicable to office-based intra-articular injections 9.
Do not exceed recommended doses: When using triamcinolone alone, adhere to FDA-approved dosing ranges 5.